280 results
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
, setting the tone for the year. Pfizer’s commercial leadership is focused on data-driven opportunities across several key growth brands, both in the U.S … , and bispecific antibodies, including other immuno-oncology biologics; and is focused on expanding its leadership in four main cancer types: breast
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
women, ensure equal opportunities for leadership and access to reproductive health.” Such a report should identify and explain trends of incongruent … latest ESG Impact Report, stating: “We aim to end discrimination against women, ensure equal opportunities for leadership and access to reproductive health
8-K
EX-99
rrki6pxc9i
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
k5ckcz5h189z6trt4
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99.1
tsz ef2m2
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99
mb6qxy0xiyehw9t2s
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
DEFA14A
0z23gvfyc4 0wy
10 Apr 23
Additional proxy soliciting materials
10:40am
PX14A6G
bevnb7jiph
4 Apr 23
Letter to shareholders
11:46am
8-K
EX-99.1
32nowo qr6b
10 May 22
Regulation FD Disclosure
7:08am
8-K
EX-99
poonm850 mckopk6d
3 May 22
Pfizer Reports First-quarter 2022 Results
8:08am
8-K
EX-99.1
22h l7msgp8v
12 Apr 22
Pfizer Names David M. Denton Chief Financial Officer
4:24pm
8-K
lwsp3rp7takj19ybaqwz
12 Apr 22
Pfizer Names David M. Denton Chief Financial Officer
4:24pm
DEFA14A
q2pls
11 Apr 22
Additional proxy soliciting materials
11:10am
8-K
EX-99
c51jz
8 Feb 22
Pfizer Reports Fourth-quarter and Full-year 2021 Results
8:53am